Prospective in-silico trials identify combined SK and K2P channel block as an effective strategy for atrial fibrillation cardioversion - Supplement

DOI10.5281/zenodo.13907120Zenodo13907120MaRDI QIDQ6702023FDOQ6702023

Dataset published at Zenodo repository.

Dasí Albert, Alfonso Bueno-Orovio, Rodriguez Blanca

Publication date: 9 October 2024

Copyright license: Creative Commons Attribution 4.0 International

Description

The dataset contains a Supplemental Material for the paper "Prospective in-silico trials identify combined SK and K2P channel block as an effective strategy for atrial fibrillation cardioversion",DOI: 10.1113/JP287124 Moreover, it includes 10 simulations conducted in a representative cohort of 10 non-cardioverted virtual patients that originally presented sustained AF for 5 seconds after drug simulation. The new simulations were run for 5 additional seconds, for a total duration of 10 seconds of simulated pharmacological action. The two drug treatments resulting in lower cardioversion efficacy (i.e., single SK and K2P channel block) were considered.

This page was built for dataset: Prospective in-silico trials identify combined SK and K2P channel block as an effective strategy for atrial fibrillation cardioversion - Supplement